X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Daily MedNews - 29/Sep 20:05

FDA Approves Opzelura for Atopic Dermatitis in Children

MONDAY, Sept. 29, 2025 -- The U.S. Food and Drug Administration has approved Opzelura cream 1.5 percent (ruxolitinib) for children ages 2 to 11 years with atopic dermatitis (AD).The approval is the first topical Janus kinase (JAK) inhibitor for the...

Articles similaires

Sorry! Image not available at this time

FDA Approves Opzelura for Atopic Dermatitis in Children

wn.com - 30/Sep 08:38

MONDAY, Sept. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Opzelura cream 1.5 percent (ruxolitinib) for children...

Sorry! Image not available at this time

FDA Approves Opzelura for Atopic Dermatitis in Children

wn.com - 30/Sep 04:27

MONDAY, Sept. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Opzelura cream 1.5 percent (ruxolitinib) for children...

Sorry! Image not available at this time

FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis

drugs.com - 02/Oct 21:28

THURSDAY, Oct. 2, 2025 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque psoriasis and active...

Sorry! Image not available at this time

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

drugs.com - 24/Sep 21:09

WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...

Sorry! Image not available at this time

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

drugs.com - 24/Sep 21:09

WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...

Sorry! Image not available at this time

FDA Approves Bondlido (lidocaine topical system) for the Treatment of Post-Herpetic Neuralgia

drugs.com - 25/Sep 19:09

September 25, 2025 -- MEDRx announced that the U.S. Food and Drug Administration (FDA) has approved Bondlido, a lidocaine*1 patch MEDRx Group and D....

Sorry! Image not available at this time

FDA Approves Inluriyo for Advanced Breast Cancer

drugs.com - 30/Sep 22:09

TUESDAY, Sept. 30, 2025 -- The U.S. Food and Drug Administration has approved Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the...

Sorry! Image not available at this time

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

Sorry! Image not available at this time

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

Sorry! Image not available at this time

FDA Approves Inluriyo (imlunestrant) for Adults with ER+, HER2-, ESR1-Mutated Advanced or Metastatic Breast Cancer

drugs.com - 25/Sep 20:09

INDIANAPOLIS, Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has...

Les derniers communiqués